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Summary 
The integrin O/L /52 (leukocyte function-associated molecule 1, CDlla/CD18)  mediates activa- 
tion-dependent adhesion of leukocytes. The cytoplasmic domains of O~g /52 have been demon- 
strated to modulate adhesiveness of at/52- Affinity changes of O/g /52 for its ligand or postreceptor 
events can be responsible for this modulation of adhesiveness.  To investigate the possible  role 
of the O/g /52 cytoplasmic domains in postreceptor events we constructed eDNA encoding chi- 
meric proteins with intracellular O/g /52 domains, which are responsible for C~L /52  specific in- 
tracellular interactions, and extracellular c~iro/33 (GP IIb/IIIa) domains, which allow the assess- 
ment of the receptor affinity state. The eDNA was stably transfected in Chinese hamster ovary 
cells and chimeric heterodimer formation proven by immunoprecipitations and flow cytometry. 
The chimeric receptors mediate adhesion to immobilized fibrinogen, and this adhesion is in- 
creased by phorbol myristate acetate and abolished by cytochalasin D.  However, neither treat- 
ment affects the affinity state of the chimeric receptor, suggesting involvement of the cytoskeleton 
in the regulation of r  /52 mediated cell adhesion. To exclude the possibility of postoccupancy 
affinity changes of the chimeric receptors, we locked the receptors into a high affinity state by 
creating a deletion variant. The region deleted (VGFFK) is highly conserved in integrin ce subunit 
cytoplasmic domains. Cotransfection of this deletion variant with a/3 subunit truncation (/53 
a724) and a triple mutation at 758-760 (TTT to AAA) of/32 abolishes adhesion without changing 
the affinity state.  A  single mutation (TTT to TAT) reduces adhesion by half without affinity 
change. Scanning electron microscopy reveals impaired spreading of these truncated/mutated 
chimeras. Immunofluorescence microscopy demonstrates a correlation between impaired adhe- 
sion and a decrease in the ability to form focal adhesions and to organize the cytoskeleton into 
stress fibers. These results describe the integrin/cytoskeleton interaction, the organization of the 
cytoskeleton, and cell spreading as postreceptor events modulating c~r/52 cytoplasmic domain 
mediated cell adhesion. Furthermore, we demonstrate that the cytoplasmic domain of the/52 
subunit, and within it the TTT region, are required for these postreceptor events. Additionally, 
we present a new approach, using deletion variants to lock integrins in a high affinity state without 
interfering with the investigated integrin/cytoskeleton interaction. This approach may be gener- 
ally useful to investigate the role of postreceptor events in integrin-mediated cell adhesion and 
migration. 
T 
he integrin O~L/52 (LFA-1,  CDlla/CD18)  mediates the 
activation-dependent adhesion of leukocytes with APCs, 
cytolytic targets, and endothelial cells (1-5). The augmenta- 
tion in OiL/52-dependent adhesion which follows stimulation 
of these cells by either cross-linking the TCR or by PMA 
is referred to as increased avidity or adhesiveness  (1, 2,  6). 
OCt /52 adhesiveness  is controlled by the cytoplasmic domain 
of the/52 subunit (7, 8). In particular mutations of a triplet 
of threonines in the 32 tail profoundly reduce the adhesive- 
ness of O~L /52 (8).  Altered adhesiveness of O/L /52 could reflect 
changes in the binding affinity for its counter receptors, the 
intercellular adhesion molecules (ICAMs) 1 (1, 7,  8).  Alter- 
natively, postreceptor events such as integrin/cytoskeleton as- 
sociation, cytoskeletal organization, and cell spreading may 
regulate the adhesive function of OiL /52. Both activation-de- 
pendent affinity modulation (9-11)  and postreceptor events 
(12-17) are mediated through the integrin cytoplasmic domains. 
For  another  activation-dependent integrin,  the platelet 
Parts of this work were  presented  at the annual meeting  of the American 
Heart Association  in Atlanta, GA on 8-11 November  1993. (1993. Circu- 
lation. 88:1-566). 
i Abbreviations used in this paper: CHO, Chinese hamster ovary; ICAM, 
intercellular adhesion molecule. 
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strated that upon stimulation of platelets this integrin un- 
dergoes a conformational change and a marked increase in 
its ligand binding affinity (18-20).  The affinity state of OtXlb 
33 can be assessed by soluble fibrinogen (19-22)  or by the 
mAb PAC-1, which displays a binding region, RYD, similar 
to the binding region RGD in fibrinogen and thus demon- 
strates binding characteristics  comparable to fibrinogen (9, 
10,  18, 21). 
In this work, we have evaluated mechanisms by which cyto- 
plasmic domains regulate OiL 32 adhesiveness. Since ICAMs 
are integral membrane proteins (1, 23),  they cannot be used 
for direct ligand binding studies to assess affinity. To evaluate 
the role of the cytoplasmic domains of oft B2 in modulating 
adhesiveness, we constructed chimeric integrins bearing the 
cytoplasmic domains of C~L B2 and the transmembrane and 
extracellular  domains of o~,ro 33, using the latter as affinity 
reporter.  We identified treatments that enhanced or reduced 
cell adhesion without changing the a~nity state of the chi- 
meric integrin. Moreover, previously described 32 cytoplasmic 
domain point mutations and truncations that reduce the adhe- 
siveness of OeL 32 (7, 8) alSO reduced cell adhesion mediated 
by chimeras, which were permanently locked in a high affinity 
state by a deletion in the ot subunit. Furthermore, the im- 
munolocalization and spreading ability of the chimeric inte- 
grins suggest that interaction of the integrin cytoplasmic 
domains and the cytoskeleton are involved in the regulation 
of adhesiveness of O~r 32. 
Materiah and Methods 
Cells.  Chinese hamster ovary (CHO) ceils and the human T 
lymphoma ceil line Jurkat were obtained from the American Type 
Culture Collection  (Rockviile,  MD). Chinese  hamster ovary  (CHO) 
cells were maintained in DMEM, 10% FCS (Whittaker M.A. Bin- 
products, Walkersville, MD), 2 mM t-glutamine, and 1% MEM 
nonessential amino acids (Sigma Chemical Co., St. Louis, MO). 
Jurkat cells were maintained in RPMI 1640 (Whittaker M.A. Bin- 
products), 10% FCS, and 2 mM t-glutamine. 
Aria'bodies and  Peptides.  The  axro 83  complex-specific mAb 
2G12 was provided  by Virgil Woods (University of California, San 
Diego, CA). The activation-dependent anti-a~ 33 mAb PAC-1 
(18) was generously provided by Dr. Sanford Shattil (Hospital of 
the University of Pennsylvania,  Philadelphia, PA). The mAb D57 
(anti-alto) was produced by Dr. Xianping Du (Scripps Research 
Institute).  The mAbs anti-LIBS 6  (anti-~3), 15  (anti-83), and 
PL98DF6 (anti-alr~) were generated, isolated, and characterized as 
described elsewhere (20, 24). TS1/22 (mAb specific for aL) and 
TS1/18 (mAb specific for 82) (25) were kindly provided by Dr. 
Stanley D'Souza (Cleveland Clinic Foundation, Cleveland, OH). 
Polyclonal  rabbit antisera were prepared by immunizing rabbits 
with peptides consisting of the 16 COOH-terminal  amino acids 
of at  (NH2-KPLHEKDSESGGGKD-COOH)  and  82  (NH2- 
KSATYIWMNPK.FAES-COOH)  coupled to bovine thyroglobulin 
type I (Sigma Chemical Co.). As a control for the specificity  of 
these antisera to the cytoplasmic domains of at 82, we immuno- 
precipitated surface-labeled Jurkat  cells. As described for aL 82 
(26), we obtained molecular weights of 170,000 and 90,000 on a 
nonreducing 7% SDS-PAGE (data not shown). The same molec- 
ular weights were precipitated with the 82-specific mAb TS1/18 
and TS1/22 (26). Polyclonal rabbit antisera to  the cytoplasmic 
domains of air0 (989-1008), /53 (742-762), and the extracellular 
domain of 83 are described elsewhere (9). The synthetic peptide 
GRGDSP was purchased  from Peninsula Laboratories  (Belmont, CA). 
DNA  Constructs.  The following chimeric integrins were en- 
gineered. Depicted in boldface type are amino acids of the trans- 
membrane region of Oqrb 83 and in roman face type, the cyto- 
plasmic domains of at 82: (a) a  subunit chimera and a  subunit 
deletion:  alr~ aL  (LLTILVLAMW KVGFFKRNLKEKMEA- 
GRGVP...), alr~ aL~ (the underlined region [VGFFK] of the pre- 
vious chimera was deleted); (b) 8 subunit chimera, deletion, and 
mutations: 33 32 (LLrrlKALIHLSDLREYRRFEKEKLKSQWN- 
NDNPLFKSATTTVMNPKFAES), 83 82 TAT (the underlined re- 
gion was mutated to TAT), 83 82 ^^^ (the underlined region was 
mutated to AAA, 83 aTa (33 was truncated LL1TIHD). 
cDNA clones of a~ (27) and 83 (28), subcloned in pBluescript 
II KS (Stratagene, La Jolla, CA), and reverse transcribed cDNA 
from the human T lymphoma line Jurkat were used as templates 
for PCR. For the chimeric DNA constructs a~r~ aL and a~ro aLa 
the sequence 5'-CAG ATA GGA ATC GCG ATG TTG GTG (al~: 
2216-2240; 27) was used as a sense primer (15 pmol/50/A) and 
the sequence 5'-GCG TCG ACG TTA ACG GCA GAA "IGC AGG 
CAG AG-Y (aL: 3364-3684; 29)  as  an  antisense primer  (15 
pmol/50 #I) with the additional cloning sites Sail and HpaI. A 
third sense primer with 25 bp up- and downstream of the fusion 
site was used at 1/20 (0.75 pmol/50 #1) of the concentrations of 
the other two primers. The PCR was performed in a single step 
reaction with these three primers and two templates, pBluescript 
ai~b and reverse transcribed Jurkat cDNA. The initial PCR cycles 
produced an intermediate product  (cytoplasmic domain of at) 
which is automatically  used as a megaprimer in the following PCR 
cycles (total of 30 cycles). After digestion with BgllI and SalI the 
PCR product was subcloned into pCDM 8 IIb (30) using BamHI 
and the Sail-compatible  XhoI restriction site. For the chimeric  DNA 
construct 83 B2 the sequence 5'-GC~ TGG CTG GGA TCC CAG 
TGT GAG -Y (83: 1478-1510; 31) was used as a sense primer (15 
pmol/50 #1) and the sequence 5'-CCG CTC GAG TGA TCA GTG 
CTC CTA ACT CTC AGC AA-Y (32: 2378-2398; 32) as an an- 
tisense primer (15 pmol/50 #1) with the additional cloning sites 
XhoI and Bell. A third sense primer with 25 bp up- and down- 
stream of the fusion site was used at 0.75 pmol/50/A. PCR was 
performed as described above. After digestion with MAul and Xhol, 
the PCR product was subcloned into pCDM 8 Ilia (30). 83 32 T^r 
and 83 B2 ~^ were constructed by PCR, using 33 82 as template 
and the above described sense primer 82: 2378-2398, and 5'-GGA 
CTC GAG CTA ACT CTC AGC AAA CTT GGG GTT CAT 
GAC CGC CGC GGC GCT CTT GAA AAG GGG-Y, respec- 
tively 5'-GGA CTC GAG CTA ACT CTC AGC AAA CTT GGG 
GTT CAT GAC CGT CGC GGT GGC GCT CTT GAb. AAG 
GGG-Y as antisense primers. The PCK products were subeloned 
as described for 83 82. 3 ru was constructed as described elsewhere 
(9). All PCR products were sequenced using the Sequenase kit  TM 
(United States Biochemical Corp., Cleveland, OH). 
Generation of Stable Cell Lines.  CHO cells were transfected  by 
electroporation (Electroporator model ECM 600; BTX Inc., San 
Diego, CA) using 370 V, 960/~F, and Ro (timing resistor: 48 fl). 
10/~g of the a  and 3  subunit in pCDM8 and 0.5 #g pCDM8 
with a neomycin  resistance  gene insert (generous  gift of  Dr. J. Loftus, 
Scripps Research Institute) were resuspended in 1.5  x  107 cells 
per 800 #1 regular cell culture medium. Before and after the dec- 
troporation,  this suspension was kept at room temperature for 
10 rain. After 2 d in reguhr cell  culture medium, cells  were selected 
for  resistance to  700  #g/ml  G418 (Genetecin; GIBCO-BRL, 
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sion with mAb D57 on a flow cytometer (FACStar|  Becton Dick- 
inson, San Jose, CA). Individual cell clones were examined on a 
flow cytometer (FACScan|  Becton Dickinson) with mAbs D57, 
2G12, and Ab15 as following: 300,000 cells per 50 91 were incubated 
with 10/~g/ml mAb in modified Tyrode's buffer (150 mM NaC1, 
2.5 mM KC1, 12 mM NaHCO~, 2 mM MgC12, 2 mM CaC12, 1 
mg/ml BSA, and 1 mg/ml dextrose, pH 7.4) for 30 min at 4~ 
After one wash in modified Tyrode's buffer, cells were incubated 
with 1/50 FITC-conjugated goat anti-mouse F(ab')2 (Tago Inc., 
Burlingame, CA) for 30 min at 4~ 
Adhesion of Transfected ClIO  Cells on Immobilized Fibrinogen. 
Fibronectin-depleted fibrinogen was diluted in PBS, pH 7.4, to 
20/~g/ml and 100/~1 aliquots incubated in the wells of a 96-well 
Immulon  II plate (Dynatech Laboratories,  Inc.,  ChantiUy,  "CA) 
overnight at 4~  After one washing with PBS, the wells were 
blocked with 100/~1 aliquots of 10 mg/ml heat-inactivated BSA 
(fraction V; Calbiochem-Novabiochem Corp., La Jolla, CA) for 
1 h at room temperature. Cells were detached with Trypsin-EDTA 
(Irvine Scientific, Santa Ana, CA) and washed twice in modified 
Tyrode's buffer. PMA (100 nM; stock in DMSO; Sigma Chemical 
Co.), cytochalasin D  (10/~M; stock in DMSO; Sigma Chemical 
Co.), or as control DMSO incubation was done in a shaker for 
30 min at 37~  100,000 cells per well were incubated at 37~ 
or at room temperature for various time periods. The nonadherent 
cells were washed off with two rounds of pipetting. The residual 
adherent cells were quantified by a previously described colorimetric 
assay (33). Briefly, the CHO endogenous cellular acid phosphatase 
activity was used by adding 100/~1 of the following substrate/lysis 
solution to each well: 1% Triton X-100 (Fisher Scientific Co., Pitts- 
burgh,  PA),  6 mg/ml p-nitrophenylphosphate (Sigma  Chemical 
Co.), in 50 mM sodium acetate buffer, pH 5. After 1 h incubation 
at 37~  the reaction was terminated by the addition of 50 #1 of 
1 M NaOH, and read in an ELISA plate reader (Molecular Devices 
Corp., Menlo Park, CA) with a 405-nm falter. Background values, 
determined in wells coated with 1% BSA alone, were subtracted 
from each point. Adherence was expressed as a percentage of the 
number of cells adhering in the chimera with the intact 152 cyto- 
plasmic domain without any addition. These numbers were cor- 
rected for the percentage of surface-expressing  cells and compared 
with a standard curve generated using known numbers of cells. 
PAC-I Flow Cytometry.  After detachment of the transfected 
CHO cells with Trypsin-EDTA, cells were washed in modified Ty- 
rode's buffer and incubated with PMA and cytochalasin  D as de- 
scribed above. 300,000 cells per 50/zl modified Tyrode's buffer were 
then incubated with PAC-1 ascites (1:500), LIBS 6 (0.75 mg/ml), 
GRGDSP (10 mM), and biotinylated mAb D57 for 30 min at room 
temperature. After one washing in modified Tyrode's buffer and 
resuspension  in 50/~1,  cells were stained  with FITC-conjugated 
anti-mouse lgM (Tago Inc.) and 2/~1R-PE-conjugated streptavidin 
(Molecular Probes Inc., Eugene, OR) for 30 min at 4~  Cells 
were examined on a FACScan  |  with the Lysis II software, and al- 
lowed to gate on mAb D 57-positive and (as an internal control) 
on mAb D  57-negative cells. 
Binding Assays with ~l-labeled Fibrinogen.  The binding of l'~I- 
labeled fibrinogen was accomplished as previously described  (10, 
19). Cells were harvested and resuspended in modified Tyrode's buffer 
as described above for the adhesion  experiments. A  typical assay 
includes  120/~1 of cells (2  x  106 cells per tube),  40 #1 of 12Sl- 
labeled fibrinogen (Amersham International, Amersham, Bucks, 
UK; final concentration, 50 riM), and 40/~1 GRGDSP (final con- 
centration, 2 mM). After 30 min at room temperature, 50/~i ali- 
quots were ~  in triplicate on 300 ~1 of 20% sucrose in modified 
Tyrode's buffer and centrifuged for 3  min  at  12,000  rpm.  *2Sl- 
labeled fibrinogen associated with the cell pellet was determined 
by scintillation spectrometry. 
Su#ce  Labeling and lmmunotrrecipitations.  Stably  transfected 
CHO cells were surface labeled with lmI (Amersham, Arlington 
Heights, IL) by using Iodogen (Pierce, Rockford, IL). 1 mg/ml 
Iodogen was dissolved in 150/~1 chloroform in a 14-ml Falcon 2059 
tube. After evaporation of the chloroform, Iodogen formed a layer 
on the bottom of the tube. After two washings with modified Ty- 
rode's  buffer,  107 ceils were added  in  500/zl  modified Tyrode's 
buffer.  The labeling  was started with the addition of 1 mCi 12sI 
and continued for 15 min at room temperature./~fter three washings 
in modified Tyrode's buffer and 10 mg/ml KI, cells were solubi- 
lized in lysis buffer (modified Tyrode's buffer: 1% Triton X-100, 
0.02% NAN3, 1 mg/ml N-ethylmaleimide,  2 mM Benzamide,  100 
#M Leupeptin, and 2 mM PMSF).  Overnight, cell extracts were 
immunoprecipitated  with preimmune rabbit antiserum,  mAb 2G12, 
polyclonal rabbit antisera directed against the extracellular domains 
of/J3 (anti-ex~3),  and polyclonal rabbit antisera  directed against 
the cytoplasmic domains of c~l~ (anti-cax,lb), B~ (anti-q83), C*L (anti- 
CC~L), and ~  (anti-c4~3) at 4~  The precipitation was carried out 
by incubation with protein G-coupled Sepharose beads for 2 h at 
4~  and a subsequent pelleting by centrifugation. The Sepharose 
beads containing the antibody-antigen complex were washed three 
times in the following buffer: modified Tyrode's buffer, 1% Triton 
X-100, 0.02% NAN,, 0.2% SDS, 1% deoxycholic acid, 1 mg/ml 
N-ethylmaleimide, and 2 mM Benzamide. Beads were resuspended 
in sample buffer, boiled for 3 min, centrifuged, and the precipi- 
tated proteins were resolved by SDS PAGE (nonreducing 7% acryl- 
amide gels). The gels were dried and then visualized by autoradi- 
ography. 
Scanning Electron and Iraraunofluorescence Microscopy.  Glass cov- 
erslips (12 mm circular, No 1; Fisher Scientific) were coated with 
20/zg/ml fibrinogen in PBS overnight at 4~  followed by blocking 
with 1% BSA (fraction V; Calbiochem-Novabiochem Corp.) for 
1 h at room temperature. After detachment and two washes  in 
DMEM, CHO cells transfected with chimeric integrin receptors 
were allowed to adhere in DMEM medium without FCS for 2 h 
at 37~ 
For scanning electron microscopy, after one PBS wash, cells were 
initially fixed in modified Karnovsky's  fixative (1% paraformalde- 
hyde,  1.5% glutaraldehyde in 0.1  M  Cacodylate buffer,  pH 7.4) 
for 1 h at 4~  and postfixed in 1% OsO4 in the same buffer for 
1 h at room temperature. Cells were then dehydrated in graded 
ethanol, critical point dried in Freon 13, and coated with a thin 
carbon film by a Hummer sputter coater. Preparations were viewed 
and photographed on a Hitachi S-600 scanning electron microscope. 
For immunofluorescence microscopy, cells were fixed with 2% 
paraformaldehyde and 0.5% Triton X-100 in PBS for 10 min on 
ice. Cells were washed twice with PBS and incubated with 5 #g/ml 
PL98DF6  (anti-~v,b) for 30 rain at  room temperature (13, 24). 
After two washes  with  PBS, cells were incubated with  FITC- 
conjugated goat anti-mouse F(ab')2 (Tago Inc.) at 1/50 and rhoda- 
mine phalloidin (Sigma Chemical Co.) at 0.1/~g/ml for 30 rain 
at room temperature. The coverslips were then washed and mounted 
in  FITC-Guard  TM  mounting media  (Testog Inc.,  Chicago,  IL). 
Photographs  were taken with  Kodak Tmax 400 film  (Eastman 
Kodak Co., Rochester, NY) on a Leitz Orthophan microscope with 
a plan Apochromat 100x  oil immersion objective. 
Results 
Alterations in the Adhesiveness of a Chimeric lntegrin with crt 
Bz Cytoplasmic Domains Are Mediated by Postreceptor Events. 
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Figure  1.  Surface  expression and verification of the chimeric character 
of the transfected integrins. (A) Comparison of untransfected CHO cells, 
o/rib/33, and O/lib  O/L/33  32 transfected CHO cells in flow cytometry. Cells 
were stained  with mAb TS1/22 (as negative  control), 2G12  (complex-specific 
anti-O/iib[33),  D  57 (anri-Oenb),  and Ab 15 (anti-3~), each 10/zg/ml. The 
detailed protocol is described in Materials and Methods. (B) Stably trans- 
fected CHO cells were surface labeled with 12sI. After solubilization, call 
extracts were incubated overnight at 4~  with preimmune rabbit antiserum, 
mAb 2G12, polyclonal rabbit  antisera directed against the extracelhlar 
domain of [33 (anti-ex~a),  against the cytophsmic  domains of O/lib (anti- 
cotnO, [33 (anti-cffs), O/L (anti-coeL), and 32 (anti<if2). The antibody-antigen 
complexes  were  precipitated  by  incubation with  protein  G-coupled 
Sepharose beads for 2 h at 4~  and resolved by electrophoresis on 7% 
SDS-polyacrylamide  gels under nouredncing  conditions followed by auto- 
radiography. The detailed procedure is described in Materials and Methods. 
As examples,  immunoprecipitations of the CHO transfectants O/~/[33 and 
O/lib eeL~[33  f32 are demonstrated  with two bands at 95,000 and 140,000 
Dahons. 
To examine the mechanisms by which cytoplasmic domains 
of OiL 32 regulate adhesiveness,  we fused its cytoplasmic do- 
main to the transmembrane and extracellular  domains of ol~ro 
33. After the transfection  of the cDNA constructs into CHO 
cells, these chimeric integrins were expressed on the cell sur- 
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Figure 2.  Oqlb  O/L/[33  32 chimeric receptors constitutively show adhe- 
siveness that can be increased by PMA and decreased by cytochalasin D. 
O~llb O/L/[33  [32 transfected CHO cells were allowed to adhere for 40 min 
at 37~  onto plastic microtiter  wells that were coated with 20/~g/ml 
fibrinogen. CeUs  were preincubated  with 100 nM PMA, 10/~M cytochalasin 
D, 10/~g/ml mAb 2G12, or no addition for 30 min at 37~  Adhesion 
was quantified as described in Materials and Methods. Percent adherence 
was determined and results expressed as mean _+ SD of three determinants. 
face as detected by staining with mAbs directed against CZHb 
33, Otlrb and 33 (Fig.  1 A). To verify that the chimeric cDNA 
constructs were expressed as chimeric proteins, we immuno- 
precipitated surface-radiolabeled transfected CHO cells with 
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Figure 3.  C*,b  O/L/33 32  chi- 
meric  receptors are  in  a  low 
affinity state and are activatable 
with mAb anti-LIBS 6 but not 
with PMA or cytochalasin  D. The 
binding of the activation-specific 
mAb PAC-1 to CHO cells stably 
transfected with  o/Ilb O/L/[33  [32 
chimeric receptors is examined by 
flow  cytometry.  Depicted  are 
histograms with the log of the 
fluorescence intensity on the ab- 
scissa and the cell number on the 
ordinate.  PAC-1 staining as de- 
scribed in Materials and Methods 
is compared in the presence  (dotted 
line) or absence  (solid line) of 2 mM 
GRGDSP. This peptide inhibits 
specific binding of mAb PAC-1 
and fibrinogen to the extraceUular 
parts of oqro/[33. Thus, with su- 
perimposable histograms in the presence or absence of GRGDSP only 
unspecific binding is present and thus, the staining is negative. With no 
addition,  the superimposable histograms in the presence or absence of 
GKGDSP show a constitutively low affinity state. The addition of LIBS 
6 causes a high affinity binding of PAC-1 that  is inhibited by 2 mM 
GKGDSP. The addition  of 100 nM PMA, 10 #M cytochalasin D,  and 
the combination of PMA and cytochalasin D in the presence or absence 
of GKGDSP show superimposable histograms and therefore a low affinity 
state of the chimeric receptor. 
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o/xib, and B3 (Fig.  1 B). The O/Hb /$3 specific mAb 2G12 and 
polyclonal antiextracellular domain of/$3  (anti-ex/$3),  and 
polyclonal anticytoplasmic domain of o/xib (anti-eerie) and/$3 
(anti-c,8~) immunoprecipitated wild-type o/wo/$3 from CHO 
cells. Whereas the monoclonal and polyclonal antibodies to 
the extracellular domains immunoprecipitated the chimera, 
the anti o/iib/$3 cytoplasmic domain antibodies failed to do 
so (Fig.  1 B). In contrast, antibodies against the cytoplasmic 
domains of O/L and/$2 immunoprecipitated the chimera, but 
not wild-type o/lib/$3 (Fig.  1 B).  Thus,  chimeric proteins 
containing the extracellular and transmembrane domains of 
O/lib  /$3 joined to the cytoplasmic domains of O/L  f12 are ex- 
pressed on the surface of these transfected CHO  cells. 
To evaluate the adhesiveness  of the chimeric receptor, we 
assessed  its  capacity to  mediate adhesion  to  immobilized 
fibrinogen.  CHO  calls bearing the chimeric receptor con- 
stitutively adhered to fibrinogen and this adhesion was medi- 
ated by the transfected receptor because it was blocked by 
a mAb directed against the extraceUular domain of O/lib  /$3 
(Fig.  2). PMA addition increased the adhesion of the trans- 
fected CHO cells, whereas cytochalasin D treatment reduced 
it (Fig.  2). The addition of PMA failed to overcome the in- 
hibitory effect of cytochalasin D. 
To examine the affinity state of the chimera, we used the 
binding of mAb PAC-1,  a mAb specific for the high affinity 
state of o/iib B3 (9,  18,  21).  Specific binding of PAC-1  can 
be inhibited by the ligand mimetic peptide GRGDSP. There 
was no specific, GRGDSP inhibitable PAC-1 binding to the 
chimera in the presence or absence of PMA or cytochalasin 
D.  Thus,  the chimeric receptor was in a low affinity state 
that was unchanged by the drugs used to modulate adhesive- 
ness. Nevertheless,  the chimeric receptor was functional, since 
addition of the anti LIBS6 antibody resulted in PAC-1 binding 
that was specifically inhibited by GRGDSP (Fig.  3). Thus, 
incubation  of the chimera transfected cells with  PMA or 
cytochalasin D  changes adhesiveness  without changing the 
affinity state of the chimeric receptor. 
Regulation of Adhesiveness of the Chimeric Receptor by Post- 
receptor  Events.  The foregoing experiments suggest that post- 
receptor events are responsible for the changes in adhesive- 
ness provoked by cytochahsin D and PMA. Nevertheless, since 
ligands may activate integrins  (22),  it  is possible  that  the 
different treatments influenced the capacity of the chimera 
to enter the high affinity state after interaction with fibrinogen. 
To exclude this possibility, we constructed receptors perma- 
nently locked in a high affinity state. A complete truncation 
of the cytoplasmic domain of o/lib (A991)  induces a high 
affinity state (9), whereas a shorter truncation of o/lib (A996) 
results in a low affinity state (10). The difference between 
these truncations is the retention of a sequence highly con- 
served in all known integrin o/subunits.  We therefore pro- 
Figure 4.  /3 subunit  truncation and mutations in the TTT region of Bz do not change  high aifinity state of the o/tr~ O/tA chimeric  receptors. (/t) 
(Tbp) Flow cytometry with o/,ib ata//33/32,  oqib Q~LA//33  A724, O~lib  O/LA//33 /32 TAT, and Otlib OILA//33 /32 AAA transfected CHO cells shows similar surface 
expression levels by staining  with mAb D57 (anti-~lib; so/id line), mAb 2G12 (anticomplex  oqib/33; data not shown),  and mAb 15 (anti-/33; data not 
shown)  compared  with a nonspecific mAb binding (dotted line). The selected cell lines have small percentages of nonexpressing  cells. (Bottom) PAC-1 
staining as described in Materials and Methods is compared  in the presence (dotted line) or absence (solid line) of 2 mM GRGDSP. This peptide inhibits 
specific binding of mAb PAC-1 and fibrinogen  to the extracellular parts  of o/lib//33. The GRGDSP inhibitable binding of PAC-1 demonstrates  a high 
af~nity state in oqib o/ta//33/32,  o/lib CtL~I/33 ~724, txm, O/I~//33 /32 ^~, and Otxib O/L~1/33  /32 TAT transfected CHO cells. As internal  control, gating of 
the nonexpressing  cells did not show GRGDSP inhibitable  PAC-1 binding (data not shown).  No addition  (solid line); GRGDSP addition  (dotted line). 
(B) Binding of lzSI-labeled  fibrinogen  to olin,  OTL6//33 /32,  o/llb O/LA//33  A724, O/lib O/LA//33 /32 AA^, ~nd o/llb O/LA//33 /32 TAT transfected CHO cells reveals 
a spontaneous  binding of fibrinngen  that is inhibitable  by GRGDSP and the blocking mAb 2G12 (data not shown),  indicating  a high atfinity state 
of the chimeric  receptors.  Results  are the mean  _+  SD of three  determinations. 
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Figure  5.  B subunit truncations/mutations and cytochalasin  D decrease 
the adhesiveness  without changing the receptor afhnity. (A) Transfected 
CHO cells were allowed to adhere for 20 min at room temperature onto 
plastic microtiter wells that were coated with 20 #g/m1 fibrinogen. Cells 
were preincubated with 10 #M cytochalasin  D, 10 #g/ml mAb 2G12, or 
no addition for 30 rain at 37~  Adhesion was quantified as described 
in Materials and Methods. Percent adherence was determined and results 
expressed as mean + SD of three determinations. (B) Incubation with 
10 #M cytochalasin  D did not change the high affinity  state of o/lro o/ta/fl3 
~2,  o/lib  O/LA/~3 A724, O/lib O/LA/~3 ~2 TAT, and O/lrb O/La/t53 /32 t~. Flow 
cytometry with mAb PAC-1 demonstrates GRGDSP  inhibitable binding 
of PAC-1 with or without cytochalasin D. Staining procedures are de- 
scribed in Materials and Methods. (Thick line) No addition; (thin line) 
cytochalasin D; (dotted  line) cytochalasin D and GKGDSP. 
duced a mutation in the C~L tail by deleting the VGFFK se- 
quence.  This mutant,  oe[r, OLLa, when cotransfected with the 
/33/32 chimera,  spontaneously bound the mAb PAC-1  and 
12SI-labeled fibrinogen, indicating a high affinity state (Fig. 
4). Incubation of oeta transfected cells with metabolic inhib- 
itors such as NaN3 and 2-deoxyglucose do not change the 
high affinity state (10). Moreover, neither a 3  subunit trun- 
cation (f13 a~z4) nor alanine  substitutions (B2 AAA, ,62 TAT) 
diminished the capacity of the chimeric receptor to sponta- 
neously bind mAb PAC-1 or lzSI-labeled flbrinogen (Hg. 4). 
Thus,  the alterations in the/3 cytoplasmic domain did not 
influence the high affinity state of the chimeric receptor, and 
effects of these alterations on adhesiveness could be studied 
in a receptor fixed in the high  affinity state. 
When  we analyzed  the  adhesion  of these high  affinity 
chimeras to fibrinogen, we found that cytochalasin D  com- 
pletely  inhibited  the  adhesion  of the  transfected  cells  to 
fibrinogen (Fig. 5 A). Nevertheless, cytochalasin D  did not 
alter the affinity state (Fig. 5 B) as assessed by mAb PAC-1 
binding.  Truncation mutants  and the alanine  substitutions 
are known to profoundly reduce the adhesiveness  of OeL /32 
(7, 8) and these mutations had similar eff~ts on the adhe- 
siveness  of the chimera.  Both/33 a724 and/32  ^^^ virtually 
abrogated adhesion (Fig. 5 A) with no effect on the affinity 
state (Fig. 4 and Fig.  5 B). The alanine point substitution 
/32 TAT reduced adhesion by ~50%,  again with no influence 
on the affinity state (Fig. 5 A  and B). Thus, cytochalasin D 
and the cytoplasmic domain mutations in/32 profoundly re- 
duced adhesiveness without  influencing  the affinity state. 
Effect of  B2 Cytoplasmic Domain Mutations on Cell Spreading 
and Organization of Focal Adhesions.  Postreceptor events that 
follow the initial integrin-mediated cell contact include the 
reorganization of the cytoskeleton as manifested by the for- 
mation of stress fibers,  the localization of integrins  at focal 
adhesions and integrin-mediated  cell spreading  (12-17,  24, 
34-36). The foregoing experiments showed that cytoplasmic 
domain  mutations  in  the  /32  cytoplasmic  domain  could 
influence cell adhesion to fibrinogen without changing the 
affinity state of the integrin.  To ascertain that postreceptor 
events are involved, we assessed the effect of these mutations 
on cell shape and cytoskeletal assembly. The cells bearing the 
wild-type/32 chimera combined with  the wild-type OeL or 
OeLa spread extensively 2 h after plating on fibrinogen-coated 
coverslips  (shown for ata in Fig.  6 A).  In sharp contrast, 
both the/33 a72, and the B2 A^^ showed a complete lack of 
cell spreading (Fig. 6, B and/9).  The point mutation of the 
TTT to TAT resulted in impairment of spreading.  Here, most 
of the cells manifested a spindle shape and failed to spread 
fully (Fig. 6 C). To further document and quantify this differ- 
ence between the/32 TAT mutant  and the wild-type/32 cy- 
toplasmic domain, we enumerated the shapes of cells bearing 
each chimera.  64% of cells bearing the wild-type 32 cyto- 
plasmic domain were fully spread, 4% were bipolar, and 32% 
were rounded (n  =  566). In contrast, 3% of the cells bearing 
32 T^T  were  well spread,  the  majority  (55%)  manifested 
bipolar shape,  and 4I%  of cells were rounded  (n  --  385). 
Thus,  the effects of the/32 cytoplasmic domain mutations 
on adhesiveness  correlate with their effects on cell spreading. 
As postreceptor events, integrins  also initiate the forma- 
tion  of stress  fibers  and  focal  adhesions.  To  assess  these 
parameters,  we examined the actin  cytoskeleton by rhoda- 
mine phalloidin staining and the localization of the chimeric 
integrin  to  focal  adhesions  by  staining  with  an  anti-oewo 
mAb (24).  The wild-type f12 cytoplasmic domain, combined 
320  Modulation  of Cell Adhesion by O/L 3JCytoskeleton Interaction Figure 6.  fl subunit truncation and mutations in the TTT (/32 758-760)  region impair spreading ability. Scanning electron microscopy pictures 
were generated as described in Materials and Methods after cells were allowed to adhere on fibrinogen (20/zg/ml) coated glass coverslips. After an 
incubation period of 2 h at 37~  CHO cells transfected with o~lro  OeL~/fl3 f12 developed a well spread and flattened cell shape (A). r  r  f12 TAT 
transfected CHO cells showed an impaired spreading and a spindle or triangular shape (C). oliib  O~tA/~3 A724 (B) and Olllb  cxta/B3 B2 ^^^ (/3) transfected 
CHO cells did not spread at all but remained in a rounded shape. Bars, 30/~m. 
either with the wild-type aL or the deleted aLA, initiated 
the formation of actin-containing stress fibers and integrin 
containing focal adhesions (shown for aL~ in Fig. 7, A  and 
B). In sharp contrast, the two mutations that most profoundly 
affected adhesiveness blocked the capacity to form both stress 
fibers and focal adhesions (Fig. 7, C, D, C, and H). Moreover, 
the 32  TAT mutation resulted in  a partial impairment of 
focal adhesion and stress fiber formation (Fig. 7, E and F). 
Thus, both the changes in cell shape and integrin-mediated 
cytoskeletal  reorganization  are  impaired by  the  32  cyto- 
plasmic domain mutations that reduce adhesiveness. These 
postreceptor events are impaired even when the receptor is 
fixed in the high affinity  state. 
Discussion 
The major findings of this study are: (a) using chimeric 
axlb at/33 32 integrins, the cytoplasmic domains of aL 32 
are shown to modulate adhesiveness by postreceptor events 
independent  of  integrin  affinity  changes.  (b)  The  inte- 
grin/cytoskeleton interaction, the cytoskeleton organization, 
and cell spreading are involved in the modulation of adhe- 
siveness mediated by the cytoplasmic domains of at 32. (c) 
aL/32 cytoplasmic domains are able to localize integrins at 
focal adhesions and to organize the actin cytoskeleton to stress 
fibers.  (d)  The/32 cytoplasmic domain, and within it  the 
TTT region (758-760), is required for focal adhesion forma- 
tion,  cytoskeletal  organization,  cell  spreading,  and conse- 
quently for the modulation of adhesiveness. (e) A deletion 
variant (VGFFK) of the aL subunit locks the chimeric inte- 
grin in a high affinity state without influencing the described 
postreceptor events. Since in all known integrin a  subunits 
this region is highly conserved, similar deletions in other inte- 
grins may provide a general tool to evaluate the role of post- 
receptor events in cell adhesion and migration. 
The term adhesiveness describes the ability of an adhesion 
receptor to mediate cell adhesion. Theoretically,  adhesiveness 
can be regulated by two mechanisms: either by an affinity 
change of the receptor for its ligand or by postreceptor events. 
Since the aL 32 counterreceptors ICAM-1,  ICAM-2,  and 
ICAM-3 are integral membrane proteins (1-4)  they are not 
readily available for classical ligand binding studies. Further- 
more, the isolation and solubilization of integral membrane 
proteins has the inherent problem of a potential alteration 
of their function as ligands.  Therefore, using a genetic ap- 
proach, we engineered chimeric receptors which contain the 
321  Peter and O'Toole Figure  7.  B subunit truncation and mutations  in the TTT (/~2 758-760) region impair focal  adhesions  formation  and cytoskeletal  organization. 
Immunofluorescence  pictures were generated  as described  in Materials  and Methods  after  cells were  allowed  to adhere  on fibrinogen  (20/~g/ml) coated 
glass coverslips for 2 h at 37~  Staining  alto aLa//33/32  transfected  CHO cells with  mAb PL98DF6 (anti-alrb) revealed  localization  of the transfected 
chimera in focal  adhesion  typical  structures (A). Staining  with rhodamine  phalloidin  in the same  cell  demonstrates  an extensive  cytoskeletal  organization 
in form of stress fibers (B). Beginning and ending of the stress fibers colocalize  with the focal adhesion typical stainings of the chimeric  receptor. 
cZllb C~L~/~3  /~2 TAT transfected  CHO cells reveal sparsely  distributed  and discrete  focal  contacts (E). Stress fiber formation  in these transfectants  is de- 
creased and very  discrete (F). alrb otza/~3  Li724  and airo o~ra//33 B2 AM transfected  CHO cells are not able to localize  the chimeric  receptors to focal 
adhesions and are not able to organize the cytoskeleton  to stress fibers (D and/-/). Bar, 20/~m. 
extracellular parts of aiib r3 as an affinity reporter and the 
cytoplasmic domains of OtL r2 as the region responsible  for 
the proposed postreceptor events. To remove postoccupancy 
alterations in affinity  as a potential confounding factor in our 
analyses of changes in adhesiveness, we deleted a VGFFK re- 
gion in the ol subunit and thus, generated a chimeric receptor 
fixed in a high affinity state. Neither cotransfection with trun- 
cation nor pointmutation variants of the/3 subunit nor treat- 
ment with the metabolic inhibitors NaN3 or 2-deoxyglucose 
(10) changed the high affinity state of the deleted integrin. 
These high affinity mutants allowed us to dissect  the role 
of the postreceptor events  in the modulation of cell adhe- 
sion, independent of the affinity state of the integrin. 
The  formation of focal  adhesions  in  cells  reflects  the 
clustering of integrins as transmembranejunctions between 
the extracellular matrix and the cytoskeleton (34),  and thus 
can be considered a postreceptor event.  Localization of/31 
and  /33  integrins  to  focal  adhesions  has  been  repeatedly 
demonstrated (14, 24,  35,  36).  In contrast, to our knowl- 
edge this is the first demonstration that the cytoplasmic do- 
mains of a/32 integrin can localize the adhesion receptor to 
focal  adhesions.  This  implies  an  association  of the  actin 
cytoskeleton with the cytoplasmic domains of C~L /32. Fur- 
thermore, we demonstrate that the extent of localization of 
a chimeric integrin receptor to focal adhesions correlates with 
both the spreading ability and the cell adhesion strength. Thus, 
suggesting that postreceptor events participate in the modu- 
lation of adhesiveness  of c~r/32. 
We demonstrate that the organization of the cytoskeleton 
and cell spreading are modulated by the cytoplasmic domains 
of OtL/32. PMA and cytochalasin D  are known to influence 
the cytoskeletal organization. Cytochalasin D is a potent in- 
hibitor of actin polymerization (37). PMA induces assembly 
and reorganization of the actin cytoskeleton (38,  39),  and 
capping or clustering of OtL /32 and colocalized condensation 
of cytoskeletal elements  in  leukocytes  (40-42).  Our  ex- 
perimental finding that cytochalasin D  and PMA modulate 
cell adhesion, independent of the affinity  state of the receptor, 
support the hypothesis that organization of the actin cyto- 
skeleton is an important mechanism for modulating the adhe- 
siveness of OtL /32- Furthermore,  inactivation of the GTP 
binding protein rho, which regulates the assembly of focal 
322  Modulation  of Cell Adhesion  by czL 3JCytoskeleton Interaction adhesions and actin stress fibers (43), has been shown to in- 
hibit PMA-induced, LFA-l-dependent lymphocyte aggrega- 
tion (44).  After TCR cross-linking, a direct association  of 
aL ~/2 and f-actin could be demonstrated (45).  Activation 
of neutrophils also induces an interaction between B2 and 
a-actinin (46). Modulation of adhesiveness independent of 
affinity changes has also been demonstrated for PMA stimu- 
lation of the integrin as ~1 (47, 48). Thus, there are several 
lines of evidence for the participation of the integrin/cyto- 
skeleton interaction and cytoskeletal organization in the regu- 
lation of adhesiveness of aL B2- 
The integrin/cytoskeleton association could modulate cell 
adhesion by coupling the adhesive forces of the individual 
integrin/ligand pairs. To break adhesion, all the cytoskeleton- 
coupled integrin receptors would have to be separated from 
their ligands simultaneously. This would require more phys- 
ical force than disengagement of individual integrin/ligand 
bonds. In our transfected cell lines, the degree of colocaliza- 
tion of the integrins at the ends of the actin stress fibers cor- 
related with the strength of cell adhesion. In the case of as 
Bl, quantitative measurements of cell adhesion have demon- 
strated the requirement of cytoskeletal involvement for strong 
adhesion (49). The reassembly of the actin cytoskeleton after 
leukocyte stimulation has been demonstrated (50),  and by 
using direct adhesive energy measurements, Ttzeren et al. 
(51) concluded that cytoskeletal structures, anchored to aL 
B2, may contribute to the strength of adhesion of activated 
T  lymphocytes. 
Experimental data with other types of adhesion molecules 
such as cadherins,  selectins, and CD44 support the impor- 
tance of interactions between cytoskeletal proteins and the 
cytoplasmic domains of adhesion molecules for the modula- 
tion of adhesion. For N- and E-cadherin, the direct partici- 
pation of the cytoplasmic domain in cell adhesion and inter- 
action with the cytoskeleton could be demonstrated (52-54). 
A truncation of the cytoplasmic domain of L-selectin abol- 
ishes leukocyte adhesion and rolling without changing the 
lectin activity of L-selectin (55). Treatment of cells bearing 
the wild-type L-selectin with cytochalasin B abolished adhe- 
sion as well, without affecting the carbohydrate binding (55). 
The adhesion molecule CD44 is dependent on its cytoplasmic 
domain for strong cell adhesion to immobilized hyaluronic 
acid (56) and for normal cell migration (57). 
Hibbs et al. (7, 8) demonstrated that the cytoplasmic do- 
main of/32  (and  especially  a  region of three contiguous 
threonines at ~2 7ss-760) is important for the regulation of 
adhesiveness of aL B2. In our experiments we found a corre- 
lation between the extent of mutation at the identical region 
(TTT to AAA and to TAT) and the degree of impairment 
in the integrin/cytoskeleton interaction. The corresponding 
region in B1 and/33 integrins may have a similar functional 
importance. Mutants lacking the ~81 cytoplasmic domain, or 
an alternative  splice variant, which both exclude the motif 
VTT (Bt 792-794), lose the ability to localize to focal adhe- 
sions (15, 16). Recently, a mutation in the cytoplasmic do- 
main of the B3 chain from TST  (B3  751-753) to  TPT was 
identified in a variant  of Glanzmann thrombasthenia (11), 
and additionally was shown to impair interaction of allb •3 
with the cytoskeleton (58). Thus, the TTT region in B2 and 
the corresponding regions in other integrin/3 subunits seem 
to be important for the interaction between the cytoplasmic 
domain and the cytoskeleton. 
Besides the described postreceptor events, affinity changes 
of the integrin may be responsible for the regulation of adhe- 
siveness of aL 32. Two experimental findings argue for the 
existence of different affinity states of ag ~2. First, at least 
two mAbs (mAb24 and NKI-L16) are proposed to bind with 
different affnities to aL ~2, dependent on cell maturation, 
cell activation, and divalent cations (59-62). Second, a com- 
petitive binding assay with soluble  ICAM-1 proposed an 
afffnity change of a fraction of the ag ~2 integrins (63). 
Thus, taken together with our experimental findings, modu- 
lation  of  ag  ~2  mediated  adhesion  may  involve  both, 
changes in affinity and in the integrin/cytoskeleton interac- 
tion, either simultaneously or sequentially. Figdor et al. (60) 
proposed a model of three activation states of ag ~2: (a) an 
inactive state with no exposure of the NKI-L16 epitope; (b) 
an intermediate activation state with exposure of the NKI- 
L16 epitope; and (c) an active state defined by cell adhesion 
or aggregation after TCR cross-hnking or PMA stimulation. 
This modal is based on the observation that the expression 
of the NKI-L16 epitope is a prerequisite, but is not suffdent 
for ag ~2 mediated cell aggregation (61, 62). This model is 
particularly attractive,  since resting lymphocytes express no 
or only partially the NKI-L16 epitope and mature lympho- 
cytes express the NKI-L16 epitope. The transition from state 
2 to state 3 in Figdor's model can be explained by modula- 
tion of the integrin/cytoskeleton interaction. This would imply 
the acquisition of a high aL B2 affinity during maturation 
of lymphocytes and a fast change in adhesiveness during lym- 
phocyte activation due to changes in the cytoskeletal organi- 
zation and the integrin/cytoskeleton association. 
The integrin chimera with the full-length cytoplasmic do- 
main of aL and the chimera with the VGFFK-deleted cyto- 
plasmic  domain  of ag  did  not  differ  in  their  ability  to 
mediate cell spreading, to initiate focal adhesions, and to or- 
ganize the cytoskeleton to stress fibers. This implies that the 
GFFKR region, which is conserved in all known integrin 
ot subunits, is essential for the regulation of integrin affinity 
but that this region is not required to mediate integrin/cyto- 
skeleton interaction, as far as examined by us. Thus, we de- 
scribe a method to lock an integrin in a high affinity state 
without changing the investigated interactions with the cyto- 
skeleton. This method may be of general use for all integrins 
and thus may allow to examine the role of postreceptor events 
in cell adhesion and migration independent of affnity changes. 
In conclusion, our data demomtrate that ~  32 cytoplasmic 
domains can modulate integrin adhesiveness independent of 
affnity changes of the integrin. Integrin/cytoskeleton associ- 
ation, the cytoskeletal organization, and cell spreading are 
directly modulated by at B2 cytoplasmic domains. The 32 
subunit cytoplasmic domain, and within it the TTT region, 
are required for the integrin/cytoskeleton interaction and for 
efffdent cell adhesion. These findings may direct experimental 
323  Peter and O'Toole and therapeutic efforts to influence Oft B2 mediated firm ad-  cytoskeletal organization or the integrin/cytoskeleton inter- 
hesion of leukocytes to endothelium with drugs influencing  action of Otr ~2. 
The authors thank Dr. Mark H. Ginsberg for helpful discussions in the design of the experiments,  and 
Drs. Xiaoping Du, Stanley D'Souza, Sanford J. Shattil, and Virgil Woods for providing antibodies.  We 
thank Drs.  Randall J.  Faull and Jail Yl~inne for critical discussions. 
This work was supported by a project grant from the German Research Foundation to K. Peter (DFG: 
Pe 441/1-1). 
Address correspondence to Dr. Karlheinz Peter, Innere Medizin III, Universitiit Heidelberg, Bergheimerstr. 
58, 69115 Heidelberg,  Germany. 
Received for publication  25 March  1994 and in  revised form  16 August  1994. 
References 
1.  Springer, T.A. 1990. Adhesion receptors of the immune system. 
Nature (Lond.). 346:425-434. 
2.  Springer, T.A. 1994. Traf~c signals for lymphocyte recircula- 
tion and leukocyte emigration: the multistep paradigm.  Cell. 
76:301-314. 
3.  Bevilacqua, M.P. 1993. Endothelial-leukocyte  adhesion mole- 
cules. Annu.  Rev. lmmunol.  11:767-804. 
4.  Hynes, R.O., and A.D. Lander. 1992. Contact and adhesive 
specificities in the associations, migrations, and targeting of 
cells and axons. Cell. 68:303-322. 
5.  Hynes, R.O. 1992. Integrins: versatility, modulation, and sig- 
nalling in cell adhesion.  Cell. 69:11-25. 
6.  Dustin, M.L., and T.A. Springer. 1989. T cell receptor cross- 
linking transiently stimulates adhesiveness through LFA-1. Na- 
ture (Lond.). 341:619-624. 
7.  Hibbs,  M.L., H. Xu, S.A. Stacker, and T.A. Springer.  1991. 
Regulation of adhesion to ICAM-1 by the cytoplasmic domain 
of LFA-1 integrin/3 subunit. Sc/ence  (Wash. DC). 251:1611-1613. 
8.  Hibbs, M.L., S. Jakes, S.A. Stacker, IL.W. Wallace, and T.A. 
Springer. 1991. The cytoplasmic domain of the integrin lym- 
phocyte function-associated antigen 1 B subunit: sites required 
for binding to intercellular adhesion molecule 1 and the phorbol 
ester-stimulated  phosphorylation  site. J.  Extz  Med.  174: 
1227-1238. 
9.  O'Toole,  T.E.,  D. Mandelman, J. Forsyth, S.J. Shattil, E.F. 
Plow, and M.H. Ginsberg.  1991. Modulation of the af~nity 
of integrin cxxr~/33  (GP IIb-IIla) by the cytoplasmic domain of 
Oqlb. Science (14fish. DC).  254:845-847. 
10.  O'Toole,  T.E., Y. Katagiri,  R.J. Faull, K. Peter, g. Tamura, 
V. Quaranta, J.C. Loftus, S.J. Shattil, and M.H. Ginsberg. 1994. 
Integrin cytoplasmic domains mediate inside-out signal trans- 
duction. J.  Cell Biol. 124:1047-1059. 
11.  Chen, Y., I. Djaffar, D. Pidard,  B. Steiner, A. Cieutat, J.p. 
Caen, and J. Rosa. 1992. Ser-752 - Pro mutation in the cyto- 
plasmic domain of integrin/33 subunit and defective activa- 
tion of platelet  integrin otH~83 (glycoprotein  IIb-lIIa)  in  a 
variant of Glanzmann thrombasthenia. Pro~ Natl. Acad. Sci. 
USA.  89:10169-10173. 
12.  Chan, 13., P. Kassner, J. Schiro, H. Byers, T. Kupper" and M. 
Heler. 1992. Distinct cellular functions mediated by different 
VLA  integrin  c~  subunit  cytoplasmic  domains.  Cell. 68: 
1051-1060. 
13.  Yl~nne, J., Y. Chen, T.E. O'Toole, J.C. Loftus, Y. Takada, and 
M.H. Ginsberg.  1993. Distinct functions of integrin c~ and 
3  subunit cytoplasmic domains in cell spreading and forma- 
tion of focal adhesions. J.  Cell Biol. 122:223-233. 
14.  LaFlamme, S.E., S.K. Akiyama, and K.M. Yamada. 1992. Regu- 
lation of fibronectin  receptor  distribution. J.  Cell Biol.  117: 
437--447. 
15.  Hayashi, Y., B. Haimovich, A. Rezka, D. Boettiger,  and A. 
Horvitz.  1990. Expression  and function of chicken integrin 
B1 subunit and its cytoplasmic domain mutants in mouse NIH 
3T3 cells. J.  Cell Biol. 110:175-184. 
16.  Balzac, F., A.M. Belkin, V.E. Koteliansky, Y.U. Balabanov, 
F. Altruda, L. Silengo, and G. Tarone. 1993. Expression and 
functional analysis of a cytoplasmic domain variant of the B1 
integrin subunit. J.  Cell Biol. 121:171-178. 
17.  Rezka, A.A., Y. Hayashi, and A.F. Horwitz. 1992. Identifica- 
tion of amino acid sequences in the integrin/~1  cytoplasmic 
domain implicated in cytoskeletal association.J.  CellBiol.  117: 
1321-1330. 
18.  Shattil, S.J.,J.A. Hoxie, M. Cunningham, and L.F. Brass. 1985. 
Changes in the platelet glycoprotein IIb-IIIa complex during 
platelet  activation. J. Biol. Chem.  260:11107-11114. 
19.  O'Toole,  T.E., J.C. Loftus, X. Du, A.A. Glass, Z.M. Rug- 
geri, S.J. Shattil, E.F. Plow, and M.H. Ginsberg. 1990. Af~nity 
modulation of the c~1~/33 integrin (phtelet GP IIb-IIIa) is an 
intrinsic  property of the receptor.  Cell Regul.  1:883-893. 
20.  Frelinger, A.L., X. Du, E.F. Plow, and M.H. Ginsberg.  1991. 
Monoclonal antibodies to ligand-occupied conformers of inte- 
grin c~lna83 (glycoprotein IIb-IIIa) alter receptor affanity, spec- 
ificity, and function. J. Biol. Chem.  266:17106-17111. 
21.  Taub, R., R.J. Gould, V.M. Garsky, T.M. Ciccarone, J. Hoxie, 
P.A. Friedman, and S.J. Shattil. 1989. A monoclonal antibody 
against the phtelet fibrinogen receptor contains a sequence that 
mimics a receptor recognition domain in fibrinogen. J. Biol. 
Chem.  264:259-265. 
22.  Du,  X.,  E.F. Plow,  A.L. Freelinger  1II, T.E. O'Toole,  J.C. 
Loftus, and M.H. Ginsberg. 1991. Ligands "activate" integrin 
c~H~3 (platelet  GP llb-Illa).  Cell. 65:409-416. 
324  Modulation  of Cell Adhesion by OfL B2/Cytoskeleton  Interaction 23.  Marguerie, G.A., T.S. Edington, and E.F. Plow.  1980. Inter- 
action of fibrinogen with its platelet receptor as part of a mul- 
tistep reaction in ADP-induced platelet aggregation. J. Biol. 
Chem.  255:154-161. 
24.  Yl~nne, J., M. Hormia, M. Jarvinen, T. Vartio,  and I.  Vir- 
tanen. 1988. Platelet glycoprotein IIb/IIIa complex in cultured 
cells. Localization in focal adhesion sites in spreading HEL cells. 
Blood. 1472:1478-1486. 
25.  Sanchez-Madrid, F., A.M. Krensky, C.F. Ware, E. Robbins, 
J.L. Strominger, S.J. Burakoff, and T.A. Springer.  1982. Three 
distinct antigens associated with human T-lymphocyte-medi- 
ated cytolysis: LFA-1, LFA-2, LFA-3. Proc Natl. Acad. Sci. USA. 
79:7489-7493. 
26.  Larson, R.S., M.L. Hibbs, and T.A. Springer.  1990. The leu- 
kocyte integrin LFA-1 reconstituted by cDNA transfection in 
a non hematopoetic cell line is functionally active and not tran- 
siently regulated. Cell Regul.  1:359-367. 
27.  Poncz, M., R. Eisman, R. Heidenreich, S. Silver, G. Vilaire, 
S.  Surrey,  E.  Schwartz, and J.  Bennett.  1987. Structure of 
the platelet membrane glycoprotein lib. J. Biol. Chem.  262: 
8476-8482. 
28.  Rosa, J.P., P.F. Bray, O.  Gayet, G.I. Johnston,  R.G. Cook, 
K.W. Jackson, M.A. Shuman, and R.P. McEver. 1988. Cloning 
of glycoprotein IIIa cDNA from human erythroleukemia cells 
and  localization  of  the  gene  to  chromosome  17.  Blood. 
72:593-600. 
29.  Larson, R.S., A. Corbi, L. Berman, and T.A. Springer.  1989. 
Primary structure of the leukocyte function-associated mole- 
cule-1 ot subunit: an integrin with an embedded domain defining 
a protein superfamily. J.  Cell Biol. 108:703-712. 
30.  O'Toole, T.E., J.C. Loftus, E.F. Plow, A.A. Glass, J.R. Harper, 
and M.H. Ginsberg. 1988. Efficient surface expression of platelet 
GP IIb-IIIa requires both subunits. Blood. 74:14-18. 
31.  Fitzgerald, L., B. Steiner, S. Rail, Jr., S. Lo, and D. Phillips. 
1986. Protein sequence of endothelial glycoprotein IIIa derived 
from a cDNA clone. J. Biol. Chem.  262:3936-3939. 
32.  Kishimoto, T.K., N. Hollander, T.M. Roberts, D.C. Anderson, 
and T.A. Springer.  1987. Cloning of the B subunit of the leu- 
kocyte adhesion proteins: homology to an extracellular matrix 
receptor defines a novel supergene family. Cell. 48:681-690. 
33.  Faull,  R.J., N.L. Kovach, J.M. Harlan, and M.H. Ginsberg. 
1993. Affinity modulation of integrin c~531: regulation of the 
functional  response  by  soluble  fibronectin. J.  Cell  Biol. 
121:155-162. 
34.  Burridge, K., K. Fath, T. Kelly, G. Nuckolls, and C. Turner. 
1988. Focal adhesions:  transmembranejunctions between the 
extracellular matrix and the cytoskeleton. Ann. Rev. Cell Biol. 
4:487-525. 
35.  Tawil, N., P. Wilson, S. Carbonetto. 1993. Integrins in point 
contacts mediate cell spreading:  factors that regulate integrin 
accumulation in point contacts versus focal contacts. J.  Cell 
Biol. 120:261-271. 
36.  Solowska, J., J.-L. Guan, E.E. Marcantonio, J.E. Trevithick, 
C.A. Buck, and R.O. Hynes. 1989. Expression of normal and 
mutant  avian integrin  subunit  in  rodent cells. J.  Cell Biol. 
109:853-861. 
37.  Cooper, J.A.  1987. Effects of cytochalasin  and phalloidin on 
actin. J.  Cell Biol. 105:1473-1478. 
38.  Downey, G.P., C.K. Chan, P. Lea, A. Takai, and S. Grinstein. 
1992. Phorbol ester-induced actin assembly in neutrophils:  role 
of protein kinase  C.J.  Cell Biol. 116:695-706. 
39.  Phatak, P., C. Packman,  and M. Lichtman. 1988. Protein ki- 
nase C  modulates actin conformation in human T  lympho- 
cytes, j. Immunol.  141:2929-2934. 
40.  Burn,  P.,  A.  Kupfer,  and S.  Singer.  1988. Dynamic mem- 
brane-cytoskeletal interactions: specific association of integrin 
and talin arises in vivo after phorbol ester treatment of periph- 
eral blood lymphocytes. Proc Natl. AcacL Sci. USA. 85:497-501. 
41.  Kupfer, A., P. Burn, and S. Singer.  1990. The PMA-induced 
specific association of LFA-1 and talin in intact cloned T helper 
cells.Journal of Molecular and Cellular Immunology. 4:317-325. 
42.  Haverstick, D., H. Sakai, and L. Gray. 1992. Lymphocyte adhe- 
sion can be regulated by cytoskdeton-associated,  PMA-induced 
capping of surface receptors. Am. J. Physiol. 262:C916-C926. 
43.  Ridley, A.J., and A. Hall. 1992. The small GTP-binding pro- 
tein rho regulates the assembly of focal adhesion and actin stress 
fibers in response  to growth factors.  Cell. 70:389-399. 
44.  Tominaga, T., K. Sugie, M. Hirata, N. Morii, J. Fukata,  A. 
Uchida, H. Imura, and S. Narumja. 1993. Inhibition of PMA- 
induced, LFA-l-dependent lymphocyte aggregation by ADP 
ribosylation of the small molecular weight GTP binding pro- 
tein, rho. j.  Cell Biol.  120:1529-1537. 
45.  Pardi,  R., L. lnverardi, C.  Rugarli,  and J.R.  Bender.  1992. 
Antigen-receptor complex stimulation triggers protein kinase 
C-dependent CDlla/CD18-cytoskeleton association in T lym- 
phocytes. J.  Cell Biol. 116:1211-1220. 
46.  Pavalko, F.M., and S.M. LaRoche. 1993. Activation of human 
neutrophils induces an interaction between the integrin 32-sub- 
unit (CD18) and the actin binding protein cr  J. lm- 
munol. 151:3795-3805. 
47.  Danilov, Y.N., and R.L. Juliano. 1989. Phorbol ester modula- 
tion of integrin-mediated cell adhesion:  a postreceptor event. 
J.  Cell Biol. 108:1925-1933. 
48.  Vuori, K., and E. Ruoslahti.  1993. Activation of protein ki- 
nase  C  precedes  the  integrin  mediated  cell  spreading  on 
fibronectin. J. Biol. Chem.  268:21459-21462. 
49.  Lotz, M., C. Burdsal, H. Erickson, and D. McClay. 1989. Cell 
adhesion to fibronectin and tenascin: quantitative measurements 
of initial binding and subsequent strengthening response. J. 
Cell Biol. 109:1795-1805. 
50.  Worthen, G.S., R Schwab, E.L. Elson, and G.P. Downey. 1989. 
Mechanics  of stimulated neutrophils: cell stiffening induces 
retention in capillaries. Science (Wash. DC).  245:183-186. 
51.  T6zeren, A., L. Mackie,  M. Lawrence,  P. Chan, M. Dustin, 
and  T.  Springer.  1992.  Micromanipulation  of adhesion  of 
phorbol 12-myristate-13-acetate~stimulated  T lymphocytes to 
planar membranes containing intercellular adhesion molecule-1. 
Biophys. J.  63:247-258. 
52.  Kintner, C.  1992. Regulation of embryonic cell adhesion  by 
the cadherin cytoplasmic domain. Cell. 69:225-236. 
53.  Nagafuchi, A., and M. Takeichi. 1988. Cell binding function 
of E-cadherin is regulated by the cytoplasmic domain. EMBO 
(Eur. Mol. Biol. Organ.) J.  7:3679-3684. 
54.  Nagafuchi, A., and M. Takeichi. 1989. Transmembrane con- 
trol of cadherin-mediated cell adhesion: a 94 kDa protein func- 
tionally associated with a specific region of the cytoplasmic 
domain of E-cadherin.  Cell Regul.  1:37-43. 
55.  Kansas, G.S., K. Ley,  J.M. Munro, and T.F. Tedder. 1993. Regu- 
lation of leukocyte rolling and adhesion to high endothelial 
venules through the cytoplasmic domain of bselectin. J. Extx 
Med.  177:833-838. 
56.  Lesley,  J., Q. He, K. Miyake,  A. Hamann, K. Hyman, and 
P.W. Kincade. 1992. Requirements for hyaluronic acid binding 
by CD44:  a role for the cytoplasmic domain and activation 
325  Peter and O'Toole by antibody. J.  Ex!a Med.  175:257-266. 
57.  Thomas, L., H.R. Byers, J. Vink, and 1. Stamenkovic.  1992. 
CD44H regulates tumor cell migration on hyaluronate-coated 
substrate. J.  Cell Biol. 118:971-977. 
58.  Chen, Y., T.E. O'Toole, J. Yl~inne, J. Rosa,  and M.H. Gins- 
berg. 1994. A point mutation in the integrin/33 cytoplasmic 
domain (STS'-*P) impairs bidirectional signaling through c~llb 
/33 (platelet  glycoprotein Ilb-IIIa). Blood. 84:1857-1865. 
59.  Dransfield,  I., and N. Hogg.  1989. Regulated expression  of 
Mg  2+  binding  epitope  on  leukocyte integrin  cx  subunits. 
EMBO (Eur. Mol. Biol. Organ.) J.  8:3759-3765. 
60.  Figdor, C.G., Y. v.Kooyk, and G.D. Keizer. 1990. On the mode 
of action of LFA-1. Immunol.  Today. 11:277-280. 
61.  Keizer, G.D., W. Visser, M. Vliem, and C.G.  Figdor.  1988. 
A monoclonal antibody (NKI-L16) directed against an unique 
epitope on the a-chain of human leukocyte function-associated 
antigen 1 induces homotypic cell-cell interactions.J. Immunol. 
140:1393-1400. 
62.  Kooyk,  Y.v., P.  Weder,  F.  Hogervorst,  A.  Verhoeven,  G. 
Seventer, A. te Velde, J. Borst, G. Keizer, and C. Figdor.  1991. 
Activation of LFA-1 through a Ca 2  §  epitope stimu- 
lates lymphocyte adhesion. J.  Cell Biol. 112:345-354. 
63.  Lollo, B.A., K.W.H. Chan, E.M. Hanson, V?I'. Moy, and A.A. 
Brian.  1993. Direct evidence for two ai~nity states for lym- 
phocyte function-associated antigen 1 on activated T cells. J. 
Biol. Chem.  268:21693-21700. 
326  Modulation  of Cell Adhesion by c~t 32/Cytoskeleton Interaction 